Logo image of KYMR

KYMERA THERAPEUTICS INC (KYMR) Stock Analyst Ratings

NASDAQ:KYMR - Nasdaq - US5015751044 - Common Stock - Currency: USD

46.32  -0.12 (-0.26%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to KYMR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 57.8. This target is 24.78% above the current price.
KYMR was analyzed by 26 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KYMR.
In the previous month the buy percentage consensus was at a similar level.
KYMR was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
KYMR Historical Analyst RatingsKYMR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -57 -52 -47 -42 -37 -32 -27 -22 -17 -12 -7 -2 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 46.3238.3856.1057.80101.85 - -17.14% 21.11% 24.78% 119.88%
KYMR Current Analyst RatingKYMR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-06-03 B. Riley Securities Upgrade Neutral -> Buy
2025-06-03 JP Morgan Maintains Overweight -> Overweight
2025-06-03 Morgan Stanley Upgrade Equal-Weight -> Overweight
2025-05-20 Stifel Reiterate Buy
2025-05-13 UBS Maintains Buy -> Buy
2025-05-12 Guggenheim Reiterate Buy -> Buy
2025-05-12 B of A Securities Maintains Neutral -> Neutral
2025-03-13 Citigroup Initiate Buy
2025-02-28 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-21 Stephens & Co. Reiterate Overweight -> Overweight
2024-12-27 Leerink Partners Maintains Outperform -> Outperform
2024-12-10 BTIG Initiate Buy
2024-12-06 BMO Capital Initiate Market Perform
2024-12-02 Wells Fargo Upgrade Equal-Weight -> Overweight
2024-11-18 Stephens & Co. Initiate Overweight
2024-11-06 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-11-04 UBS Maintains Buy -> Buy
2024-11-01 Guggenheim Maintains Buy -> Buy
2024-11-01 Truist Securities Reiterate Buy -> Buy
2024-09-27 Oppenheimer Maintains Outperform -> Outperform
2024-08-26 Wolfe Research Upgrade Peer Perform -> Outperform
2024-08-14 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-08-12 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-07-10 Oppenheimer Maintains Outperform -> Outperform
2024-07-09 B. Riley Securities Maintains Neutral -> Neutral
2024-06-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-03 Oppenheimer Maintains Outperform -> Outperform
2024-04-22 Oppenheimer Initiate Outperform